Evi kostenis biography

For some years now, beta blockers have been a key tool in the treatment of congestive heart failure in patients recovering from a heart attack.

They influence beta receptors in the sympathetic nervous system and thus reduce the heart’s excitability. Carvedilol is one such beta blocker that is regarded as being particularly good at prolonging the long-term survival of patients with heart failure.

This clinically impressive effect is thought to be the work of a certain molecular mechanism, which the working group led by Professor Evi Kostenis from the University of Bonn’s Institute of Pharmaceutical Biology scrutinized in detail together with a team of researchers of national and international renown.

In an extremely skillful experiment using cutting-edge biotechnological methods that modify the genetic material in human cells with pinpoint accuracy, the research